|
Real-time Estimate
Cboe BZX
16:43:16 10/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 145.00 USD | -0.44% |
|
-2.65% | +18.67% |
| 01:11pm | HSBC Adjusts Price Target on Gilead Sciences to $175 From $155, Keeps Buy Rating | MT |
| 09-09 | Gilead Sciences, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 11:00 AM |
| Market Cap | 181B 155B 146B 133B 249B 17,185B 250B 1,734B 670B 8,755B 678B 663B 27,736B | P/E 2026 * |
-44.1x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 197B 170B 160B 146B 273B 18,778B 274B 1,895B 732B 9,567B 741B 725B 30,308B | EV / Sales 2026 * |
6.43x | EV / Sales 2027 * | 5.81x |
| Free-Float |
99.88% | Yield 2026 * |
2.26% | Yield 2027 * | 2.3% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GILD | Delayed | |
CBOE
| GILD | Real-time | |
Xetra
| GIS | Delayed | |
Tradegate
| GIS | Real-time | |
Mexican S.E.
| GILD * | End-of-day quote | |
Deutsche Boerse AG
| GIS | Delayed | |
Börse Stuttgart
| GIS | Delayed | |
Borsa Italiana
| 1GILD | End-of-day quote | |
Boerse Muenchen
| GIS | Real-time | |
Wiener Boerse
| GILD | End-of-day quote | |
London S.E.
| 0QYQ | Delayed | |
Swiss Exchange
| GILD | Delayed | |
Santiago S.E.
| GILD | End-of-day quote | |
Lima
| GILDUS | End-of-day quote | |
Santiago S.E.
| GILDCL | End-of-day quote | |
Swiss Exchange
| GILD | Delayed | |
CBOE
| 0QYQ | Real-time | |
CBOE
| Real-time |
Last Transcript : Gilead Sciences, Inc.
| 1 day | -0.61% | ||
| 1 week | -2.65% | ||
| Current month | -0.47% | ||
| 1 month | +9.34% | ||
| 3 months | +16.06% | ||
| 6 months | -0.67% | ||
| Current year | +18.67% |
| 1 week | 145 | 151.18 | |
| 1 month | 132.01 | 152.55 | |
| Current year | 116.88 | 157.29 | |
| 1 year | 108.46 | 157.29 | |
| 3 years | 62.07 | 157.29 | |
| 5 years | 57.16 | 157.29 | |
| 10 years | 56.56 | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 01/03/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 01/11/2019 |
Keeley Wettan
CMP | Compliance Officer | - | 18/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 19/08/2016 |
| Director/Board Member | 73 | 01/01/2018 | |
Harish Manwani
BRD | Director/Board Member | 72 | 09/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 A | Sell | Chief Executive Officer | -15,000 | 0.0012% | ||
| 8/26/26 A | Exercice | Director | 54,000 | 0.0043% | ||
| 8/20/26 A | Exercice | Director | 15,000 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.44% | -2.65% | +25.82% | +91.64% | 181B | ||
| +0.48% | -3.09% | +49.77% | +91.69% | 1,002B | ||
| +1.17% | -2.95% | +50.93% | +66.34% | 644B | ||
| +1.12% | -4.13% | +19.24% | +68.37% | 443B | ||
| -0.82% | -3.09% | +29.84% | +36.08% | 343B | ||
| +0.75% | -13.87% | +12.27% | +28.07% | 262B | ||
| +0.47% | -3.70% | -1.83% | +11.37% | 245B | ||
| -0.40% | -11.65% | +39.75% | +50.82% | 212B | ||
| -0.66% | -4.29% | -17.81% | -57.80% | 199B | ||
| -0.99% | -4.27% | +12.42% | -18.89% | 158B | ||
| Average | +0.03% | -4.92% | +22.04% | +36.77% | 368.8B | |
| Weighted average by Cap. | +0.30% | -4.24% | +31.37% | +54.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.69B 26.41B 24.87B 22.66B 42.39B 2,920B 42.56B 295B 114B 1,488B 115B 113B 4,713B | 32.68B 28.12B 26.48B 24.13B 45.14B 3,110B 45.32B 314B 121B 1,584B 123B 120B 5,019B |
| Net income | -4.27B -3.68B -3.46B -3.16B -5.9B -407B -5.93B -41.05B -15.87B -207B -16.05B -15.7B -656B | 10.28B 8.84B 8.33B 7.59B 14.19B 978B 14.25B 98.67B 38.13B 498B 38.58B 37.74B 1,578B |
| Net Debt | 16.75B 14.41B 13.57B 12.36B 23.13B 1,593B 23.22B 161B 62.15B 812B 62.88B 61.51B 2,572B | 9.12B 7.85B 7.39B 6.74B 12.6B 868B 12.65B 87.62B 33.86B 442B 34.26B 33.52B 1,401B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | $145.65 | -0.68% | 4,583,213 |
| 08/09/26 | $146.64 | -2.88% | 6,080,502 |
| 04/09/26 | $151.00 | -0.15% | 6,181,783 |
| 03/09/26 | $151.22 | +1.08% | 4,498,099 |
| 02/09/26 | $149.61 | -0.21% | 4,923,290 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions


















